ID: ALA5204265

Max Phase: Preclinical

Molecular Formula: C23H30N2O4

Molecular Weight: 398.50

Representations

Canonical SMILES:  CC(C)(C)OC(=O)Nc1ccc(NC(=O)COc2ccccc2C(C)(C)C)cc1

Standard InChI:  InChI=1S/C23H30N2O4/c1-22(2,3)18-9-7-8-10-19(18)28-15-20(26)24-16-11-13-17(14-12-16)25-21(27)29-23(4,5)6/h7-14H,15H2,1-6H3,(H,24,26)(H,25,27)

Standard InChI Key:  SCWUVCLQNAOSIT-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type:

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 398.50

Molecular Weight (Monoisotopic): 398.2206

AlogP: 5.35

#Rotatable Bonds: 5

Polar Surface Area: 76.66

Molecular Species: NEUTRAL

HBA: 4

HBD: 2

#RO5 Violations: 1

HBA (Lipinski): 6

HBD (Lipinski): 2

#RO5 Violations (Lipinski): 1

CX Acidic pKa: 12.47

CX Basic pKa:

CX LogP: 5.18

CX LogD: 5.18

Aromatic Rings: 2

Heavy Atoms: 29

QED Weighted: 0.71

Np Likeness Score: -1.31

References

1. Wang L, Liu M, Zu Y, Yao H, Wu C, Zhang R, Ma W, Lu H, Xi S, Liu Y, Hua L, Wang G, Tang Y..  (2022)  Optimization of NAMPT activators to achieve in vivo neuroprotective efficacy.,  236  [PMID:35385807] [10.1016/j.ejmech.2022.114260]

Source

Source(1):

• Scientific Literature